Close Menu

NEW YORK (GenomeWeb) – Natera reported after the close of the market Thursday that its second quarter revenues jumped 15 percent year over year as its test volume rose sharply.

The San Carlos, California-based molecular diagnostics firm reported total revenues of $52 million, up from $45.1 million for Q2 2015 and besting the consensus Wall Street estimate of $50.6 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.